Expedition Therapeutics closes $115M Series B for COPD drug. August 10, 2026 Fundraise Insider tracks newly funded startups each week and delivers verified sales leads of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing. Expedition Therapeutics closed an oversubscribed $115 million Series B on August 5, 2026, led by General Atlantic with RA Capital and Vivo Capital joining. The existing investor base turned out in full. Sofinnova Investments, Novo Holdings, Forbion, Dawn Biopharma, Adage Capital Management, Balyasny Asset Management, Logos Capital, Sanofi Ventures, BVF Partners and Venrock Healthcare Capital Partners all participated. The timing was not accidental. The financing was announced alongside the dosing of the first patient in the company global Phase 2 trial in COPD, which is the point at which an asset stops being a preclinical story. Expedition is based in San Francisco, California, and was founded by Yi Larson, who serves as chief executive. The money carries EXPD-101, its next generation DPP1 inhibitor, through Phase 2, and funds expansion of the pharmaceutical pipeline into other inflammatory diseases along with further research discovery work.

Infinimmune has raised $75 million in a series A funding round led by Regeneron Ventures. The company develops antibody discovery technology. The startup plans to use the capital to advance its antibody discovery platform. Regeneron's venture arm headlined the investment round.

Plantible Foods has raised $35 million in USDA-backed financing to expand production of its duckweed-derived Rubisco protein. The San Diego startup secured $25 million in debt from X-Caliber Rural Capital, a USDA-licensed lender, plus $10 million in equity from RA Capital and existing investors including Piva Capital. The funding will finance up to 50 new greenhouses at Plantible's 100-acre Texas facility, increasing capacity fivefold to over 100,000 tonnes annually. The company's Rubi Protein ingredient, which received FDA clearance six months ago, offers functional properties matching egg whites whilst delivering a 70% nutritional yield. Duckweed grows in two to three days with minimal water use and contains all nine essential amino acids. Plantible has raised $92 million to date.